undamentalytics Newsletter
Sign in

Champions Oncology, Inc. balance sheet

At the end of fiscal 2026, Champions Oncology, Inc. had total assets of $27.0m, total liabilities of $22.9m and shareholders' equity of $3.9m. It held $4.9m in cash against $0 of debt: net cash of $4.9m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2018Apr 20182019Apr 20192020Apr 20202021Apr 20212022Apr 20222023Apr 20232024Apr 20242025Apr 20252026Apr 2026LTMJul 2026
Cash and equivalents138591031054
Receivables445710810111314
Total current assets581313201914221919
Goodwill1100000000
Total assets8112128353426322733
Accounts payable2332356476
Deferred revenue (current)546611131215910
Total current liabilities781211172222242019
Total debt0000000000
Total liabilities891620263028292329
Shareholders' equity025795−2444
Net debt (negative = net cash)−1−3−8−5−9−10−3−10−5−4
Shares outstanding11m12m13m13m14m14m14m14m14m14m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CSBR vs PRPOCSBR vs MASSCSBR vs PSNL

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Champions Oncology, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Champions Oncology, Inc.